… a significant correlation with the duration of treatment for COVID-19 patients. Gender (p = …
of COVID-19 patients. Comorbidities showed a significant correlation with duration of treatment …

… for severe acute respiratory syndrome coronavirus 2, the current focus is … therapies for the
treatment of coronavirus disease 2019. … as a treatment for COVID-19, more studies are needed. …

… Antivirals justifiably remain the focus for treatment in early COVID-19. Two main approaches
exist: direct acting antivirals (DAAs) that target viral proteins, and less developed host-…

… We have analysed the interaction between recent anticancer treatments and COVID-19
morbidity and mortality in the largest cohort of patients with cancer with COVID-19 presented to …

… It can significantly improve treatment consistency and decision … the treatment of COVID-19
infected patients but also for their proper health monitoring. It can track the crisis of COVID-19 …

… been marketed for the treatment of COVID-19, mostly requiring … severe or critical COVID-19
may benefit from treatment with … Here, we summarize progress with COVID-19 drug discovery…

… to the treatment of COVID-19, in Wuhan, China. We tested the hypothesis that treatment
of … , especially with RAAS inhibitors, might impact on the mortality of patients with COVID-19. …

… -6 (IL-6), emerged as an alternative treatment for COVID-19 patients with a risk of cytokine …
treatment response of TCZ therapy in COVID-19 infected patients. The demographic, treatment…

… analysis received at least one treatment intended to treat COVID-19 (Table 1, … treatments
as well as many non-descript treatments (eg, “antibiotics not otherwise specified”). Treatments …

… , or treatments for COVID‐19 that are known to work to some extent, such as remdesivir or
dexamethasone. We excluded treatments that we know do not work for COVID‐19, such as …